SCHEMBL20508325

SCHEMBL20508325

COc1ccc(-c2nnc(-c3cc4ccccc4[nH]3)o2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.68
RAB9A P51151 9/20 0.68
NPC1 O15118 8/20 0.68
MAPT P10636 8/20 0.68
CASP3 P42574 1/20 0.68
SENP8 Q96LD8 1/20 0.68
SENP7 Q9BQF6 1/20 0.68
SENP6 Q9GZR1 1/20 0.68
ALDH1A1 P00352 10/20 0.53
HPGD P15428 9/20 0.53
EGFR P00533 1/20 0.53
ERBB2 P04626 1/20 0.53
KMT2A Q03164 4/20 0.52
HSD17B10 Q99714 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
TP53 P04637 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508265 0.85 HPGD (0.60) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL20508319 0.85 NPC1 (0.57) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL20508264 0.84 NPC1 (0.61) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL20508275 0.82 RAB9A (0.65) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL23468384 0.82 S1PR1 (0.51) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL30047670 0.81 KDM4E (1.00) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL2682217 0.81 KDM4E (1.00) KDM4ERAB9ANPC1MAPTCASP3
Ammonia Solution, Strong SCHEMBL6503463 0.80 KDM4E (0.97) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL20508334 0.79 KDM4E (0.51) KDM4ERAB9ANPC1MAPTCASP3
SCHEMBL27477057 0.79 NPC1 (0.73) KDM4ERAB9ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents NORTHERN ILLINOIS RESEARCH FOUNDATION (US) 2021-06-08 US disclosed
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents NORTHERN ILLINOIS RESEARCH FOUNDATION (US) 2021-06-08 US disclosed
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS CMPK1, IPMK, ITPA KDM4E 276/4885RAB9A 4196/4885NPC1 4195/4885
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents CBR3, AOC3, AHR KDM4E 2652/4885RAB9A 4222/4885NPC1 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.